BG
KRRO icon

Bollard Group’s Korro Bio KRRO Stock Holding History

Bollard Group’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22
Closed -$2K – 344
2022
Q1 		$2K Hold
22
– – ﹤0.01% 424
2021
Q4 		$6K Hold
22
– – ﹤0.01% 423
2021
Q3 		$8K Hold
22
– – ﹤0.01% 411
2021
Q2 		$11K Hold
22
– – ﹤0.01% 408
2021
Q1 		$11K Hold
22
– – ﹤0.01% 409
2020
Q4 		$39K Hold
22
– – ﹤0.01% 356
2020
Q3 		$21K Hold
22
– – ﹤0.01% 383
2020
Q2 		$26K Buy
+22
New +$19.9K ﹤0.01% 397

Other funds holding KRRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bollard Group's KRRO Position: Q2 2022 in Review

Bollard Group sold out of Korro Bio (KRRO) in Q2 2022, closing a stake of 22 shares — an estimated $2K sold.

Bollard Group first reported a position in KRRO in Q2 2020 and held it in 8 quarters. The position peaked at $39K in Q4 2020. 58 funds tracked by Wall St. Rank hold KRRO as of Q2 2022.

  • Bollard Group reported no remaining Korro Bio position as of Q2 2022 after selling out during the quarter.
  • Bollard Group sold 22 Korro Bio shares in Q2 2022, an estimated $2K.
  • Bollard Group first reported a position in Korro Bio in Q2 2020 and held it in 8 quarters.
  • Bollard Group's Korro Bio position peaked at $39K in Q4 2020.
  • 58 funds tracked by Wall St. Rank held Korro Bio as of Q2 2022.

Based on Bollard Group's 13F filing for Q2 2022, filed 12 Aug 2022.